Screener
CG Oncology CGON PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 417 | 688 |
| Prepaid expenses and other current assets | 19,949 | 15,067 |
| Total current assets | 1,049,647 | 759,475 |
| Property and equipment, net | 14,707 | 15,596 |
| Operating lease right-of-use assets | 5,730 | 3,971 |
| Intangible assets, net | 545 | 575 |
| Goodwill | 10,297 | 10,297 |
| Other assets | 4,729 | 1,678 |
Item 1. Financial Statements.
FAQ
- What is CG Oncology's PP&E (net)?
- CG Oncology (CGON) reported PP&E (net) of $14.71M in Q2 2026.
- How has CG Oncology's PP&E (net) changed year-over-year?
- CG Oncology's PP&E (net) increased by 5713.0% year-over-year, from $253K to $14.71M.
- What is the long-term trend for CG Oncology's PP&E (net)?
- Over 2 years (2023 to 2025), CG Oncology's PP&E (net) has grown at a 1403.4% compound annual growth rate (CAGR), from $69K to $15.6M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about CG Oncology's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude